Drugs for Obstructive Airway Diseases
Drugs for Obstructive Airway Diseases Companies (5)
Drugs for Obstructive Airway Diseases News
-
News Drug Approvals from 2025 – Triumphs in the midst of challenges
The following infographic outlines key drugs that have been newly approved by the US FDA in 2025.
Drugs for Obstructive Airway Diseases Products (11)
-
Product Budesonide
Budesonide Inhalation and Intranasal Formulations are highly effective, locally acting corticosteroid medications prescribed in various microgram strengths to suppress chronic inflammation in the respiratory and nasal passages. By acting directly on target tissues, budesonide reduces mucosal swelling, mucu...
-
Product VISCOFLU ® nasal Spray
VISCOFLU nasal spray is a medical device made from 3% hypertonic saline solution at controlled pH and 6% N-acetylcysteine. Facilitates the fluidification and mechanical removal of mucusand/or mucopurulent secretions stagnant inside the nasal cavity and inside the paranasal sinuses.anti-mucolytic
-
Product MONTELUKAST
Montelukast is a daily oral medication used to prevent asthma attacks, exercise-induced bronchoconstriction, and allergy symptoms in adults
-
Product VISCOFLU® sachets
VISCOFLU sachets Systemic treatment of respiratory tract diseases characterized by thick and viscous mucosal hypersecretion.
For:
Fluidifies airways secretions.
Decongests mucosa and reduces inflammation.
Supports mucociliary clearance.
Supports the immune system.
-
Product 6% SALINE SOLUTION
6% saline solution at a glance • For inhalation in cases of bronchitis and bronchiolitis • No preservatives • Suitable for use from infancy onwards
-
Product 0.9% SALINE SOLUTION INHALATION PÄDIA
Increases the mobilisation of secretions in the lower respiratory tract in patients with persistent mucus accumulation (acute bronchiolitis, acute obstructive bronchitis and cystic fibrosis) by osmotic effects.
-
Product 3% SALINE SOLUTION
3% saline solution at a glance
• For inhalation in cases of bronchitis and bronchiolitis • No preservatives • Suitable for use from infancy onwards
-
Product Budesolv
Marinosolv® – The Enabling Technology Behind BudesolvBudesolv is an innovative aqueous budesonide formulation based on Marinosolv® drug delivery platform, which has the potential to dramatically improve the solubility and bioavailability of poorly water-soluble compounds. This leads to faster therapeu...
-
Product Theophyllinum Tramco, 1.2 mg/ml, solution for infusion
Theophyllinum Tramco belongs to a group of medicines called xanthines, which relax and expand the airways in the lungs, making breathing easier. It is used for symptomatic treatment of breathing problems due to diseases such as asthma, chronic bronchitis, emphysema, and status asthmaticus. It is ad...
Upcoming Events
-
CPHI Korea 2026
COEX, Seoul, Korea
25 Aug 2026 - 27 Aug 2026 -
CPHI & PMEC Shenzhen 2026
Shenzhen Convention & Exhibition Center (SZCEC), China
16 Sep 2026 - 18 Sep 2026 -
CPHI Milan 2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026